Journal articlesA novel treatment to delay the onset of radiotherapy-induced skin reaction

A novel treatment to delay the onset of radiotherapy-induced skin reaction

15/09/17 | Products | Deborah Glover

In this article, the author discusses current topical treatments used in the treatment of radiotherapy-induced skin reaction (RISR) and discusses an alternative, Flamigel® RT (Flen Health UK). A moderate to severe radiotherapy-induced skin reaction may necessitate a break in treatment; this novel product can reduce the onset and severity of RISR, thus potentially ameliorating treatment breaks (Harris et al, 2011; Censabella et al, 2017). The author of this article experienced a mild RISR during radiotherapy treatment that developed at about day 7. While this did not delay treatment, the effects could at times be difficult to manage. The mild discomfort was tolerable, but the worst symptom was the itching.